Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2019/0085037 NOVEL BACILLUS THURINGIENSIS GENE WITH LEPIDOPTERAN ACTIVITY
The disclosure provides nucleic acids, and variants and fragments thereof, obtained from strains of Bacillus thuringiensis encoding polypeptides having...
2019/0085036 Polypeptides Having Immunoactivating Activity And Methods Of Producing The Same
Isolated polypeptides are provided that comprise a cholera toxin B subunit variant having one or more modifications to increase the expression of the...
2019/0085035 SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or...
2019/0085034 ANTIBODY MIMIC CONJUGATES AND PARTICLES
Particles, including nanoparticles and microparticles, and pharmaceutical formulations thereof, comprising conjugates of an active agent such as a therapeutic,...
2019/0085033 IMMUNOGENIC TRIMERS
The invention relates to PGT121-germline-targeting designs, trimer stabilization designs, combinations of those two, trimers designed with modified surfaces...
2019/0085032 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE
Embodiments of HIV-1 Env ectodomain trimers stabilized in a prefusion mature closed conformation and methods of their use and production are disclosed. Nucleic...
2019/0085031 PROTEIN VARIANTS FOR USE AS LIPID BILAYER-INTEGRATED NANOPORE, AND METHODS THEREOF
The presently-disclosed subject matter relates to an engineered T3 or T4 viral DNA-packaging motor connector protein that can be incorporated into a lipid...
2019/0085030 NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF
The present invention relates to novel D-enantiomeric A-beta-oligomer-binding peptides, homologs, fragments, parts and polymers thereof and use thereof.
2019/0085029 CYCLIN-DEPENDENT KINASE 5 (CDK5) INHIBITORY PEPTIDES
The invention relates to methods and compositions for promoting cognitive function and/or treating cognitive function disorders and impairments. In particular...
2019/0085028 SYNTHETIC PEPTIDES THAT MODULATE THE NMDA RECEPTOR
The invention provides a series of peptides with N-methyl-D-aspartate (NMDA) receptor modulating activity. Specifically it contains two synthetic peptides...
2019/0085027 CYCLIC PEPTIDE DERIVATIVE, METHOD FOR PREPARING SAME AND COMPOSITION THEREOF
Provided is a cyclic peptide derivative which is derived from Paecilomyces tenuipes having an astrocyte proliferative activity, or a salt thereof.
2019/0085026 AN IMPROVED PROCESSES FOR THE PREPARATION OF CARFILZOMIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
The present invention relates to an improved process for the preparation of carfilzomib or a pharmaceutically acceptable salt thereof. The present invention...
2019/0085025 NOVEL COMPUNDS AND METHODS FOR INHIBITING CELL DEATH
This invention provides novel compounds and methods for promoting cell survival and/or plasticity, especially in neuronal cells, by targeting the microtubule...
2019/0085024 Alpha-Ketoamide Inhibitors Of Cysteine Proteases
The disclosure provides compounds comprising a .alpha.-ketoamide linkage that is terminated on each end by an amino acid, such as compounds of Formula (I),...
2019/0085023 CRYSTAL OF REDUCED GLUTATHIONE AND METHOD FOR PRODUCING SAME
The present invention provides a crystal of reduced glutathione having excellent powder properties and a method for producing the same. The present invention...
2019/0085022 PEPTOID AFFINITY LIGANDS
Disclosed herein are peptoids and related compounds, including peptoid affinity ligands, and hybrid peptoids, for binding and/or purifying immunoglobulins,...
2019/0085021 REMOVAL OF LEAKED AFFINITY PURIFICATION LIGAND
The invention provides for the removal of a large fraction of contaminants from protein preparations while maintaining a high level of recovery using tentacle...
2019/0085020 Multi-Functional Chemical Agents, and the Method for Protein Modification
A multifunctional chemical agents comprising functional agents Fn1, Fn2 and linkers, for the linchpin directed (LDM), protein directed (PDPM) modifications of...
2019/0085019 RAMAN TAG
A method of forming a probe, wherein the method includes converting cholenic acid into a compound with a terminal alkyne group, wherein the converting the...
2019/0085018 DRUG COMPOUND AND PURIFICATION METHODS THEREOF
The invention provides a method of preparing a lyophilized pharmaceutical composition containing a compound described herein or a pharmaceutically-acceptable...
2019/0085017 6-ETHER/THIOETHER-PURINES AS TOPOISOMERASE II CATALYTIC INHIBITORS AND THEIR USE IN THERAPY
The present invention relates to certain purines of the following formulae, which act as topoisomerase II catalytic inhibitors: wherein: J is independently:...
2019/0085016 MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA
This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide...
2019/0085015 MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA
This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide...
2019/0085014 MASSIVE PARALLEL METHOD FOR DECODING DNA AND RNA
This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide...
2019/0085013 NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO
This disclosure relates to nucleotide and nucleoside therapeutic compositions and uses in treating infectious diseases, viral infections, and cancer, where the...
2019/0085012 5'-Cyclo-Phosphonate Modified Nucleotides
Described are 5'-cyclo-phosphonate modified nucleotides, and oligonucleotides, such as interference (RNAi) agents, containing 5'-cyclo-phosphonate modified...
2019/0085011 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection...
2019/0085010 HCV POLYMERASE INHIBITORS
The invention provides compounds of the formula: ##STR00001## wherein B is a nucleobase selected from the groups (a) to (d): ##STR00002## and the other variables...
2019/0085009 CRYSTAL FORMS OF BETA-NICOTINAMIDE MONONUCLEOTIDE
The invention relates to crystalline forms of a .beta.-nicotinamide mononucleotide, methods of their preparation, and related pharmaceutical preparations...
2019/0085008 NICOTINAMIDE RIBOSIDE AND NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR USE IN THE TREATMENTS OF...
Provided herein are compounds of Formula (I): or a pharmaceutically acceptable salt thereof, and compositions comprising such compounds that are useful for...
2019/0085007 4-methylcatechol Derivatives and Uses Thereof
The invention relates to phenoxy derivatives with glycosidically bound sugar moieties, pharmaceutical compositions containing such compounds, uses of such...
2019/0085006 Method For Producing Low Molecular Weight Aromatic Lignin-Derived Compounds
The present invention relates to a method for producing one or more low molecular weight aromatic lignin-derived compounds. The method preferably comprises...
2019/0085005 PHOSPHONATE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS
Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or...
2019/0085004 FLUORINE-CONTAINING COMPOUND, SUBSTRATE FOR PATTERNING, PHOTODEGRADABLE COUPLING AGENT, PATTERNING METHOD, AND...
A method for producing a fluorine-containing compound represented by General formula (1), wherein X represents a halogen atom or an alkoxy group, R.sup.1...
2019/0085003 SILANE COMPOUND, RUBBER COMPOSITION AND TIRE
Disclosed are a silane compound of the general formula (1) described below, as well as a rubber composition including the same, and a tire. A silane compound...
2019/0085002 NOVEL ORGANOSILICON COMPOUND AND METHOD FOR PRODUCING SAME
Provided are an organosilicon compound capable of improving the storage stability of a composition (curability after long-term storage); and a method for...
2019/0085001 AROMATIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME
An aromatic compound which improves emission efficiency and an organic electroluminescence device including the same are provided. The organic ...
2019/0085000 SILOXANE MONOMER, COMPOSITION FOR PREPARATION OF SILICONE HYDROGEL LENS CONTAINING SAME, AND SILICONE HYDROGEL LENS
The present invention relates to a siloxane monomer used in the production of a silicone hydrogel lens, a composition for the preparation of a lens containing...
2019/0084999 CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USES THEREOF
Disclosed herein are antimicrobial compounds, compositions, pharmaceutical compositions, and the use and preparation thereof. Some embodiments relate to cyclic...
2019/0084998 PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS
The present invention relates to novel pyrimido-diazepinone compounds, methods of modulating protein kinases, including MPS1 (TTK), ERK5 (BMK1, MAPK7), LRKK2,...
2019/0084997 BICYCLIC HETEROARYLAMINOALKYL PHENYL DERIVATIVES AS PI3K INHIBITORS
This application relates to derivatives of Formula I: ##STR00001## and pharmaceutically acceptable salts thereof, which are inhibitors of PI3K, and compositions...
2019/0084996 THAILANSTATIN ANALOGS
The invention provides novel cytotoxic compounds and cytotoxic conjugates comprising these cytotoxic compounds and cell-binding agents. More specifically, this...
2019/0084995 Spiroketal-Based C2-Symmetric Scaffold For Asymmetric Catalysis
Provided herein is a compound of formula (I): ##STR00001## wherein each R is independently selected from the group consisting of C.sub.1-8 alkyl, C.sub.1-8...
2019/0084994 HEPATITIS B ANTIVIRAL AGENTS
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A-Y-L-R (I) which inhibit the...
2019/0084993 PHARMACOLOGICALLY ACTIVE COMPOUNDS
The present invention relates to compounds of formula I shown below: ##STR00001## wherein Q is as defined herein. The compounds of formula I act as selective...
2019/0084992 COMPOUND INCLUDING NITROGEN AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME
Provided are a compound including nitrogen, represented by Formula 1, and an organic electroluminescence device including the same. In Formula 1, A.sub.1 to...
2019/0084991 PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
The present application relates to novel compounds of formula (I) ##STR00001## to their utility in treating and/or preventing clinical conditions including...
2019/0084990 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE
The present invention provides novel heteroaryl compounds of formula (I) having a pyrimidine-containing core that is linked to a 4-trifluoromethoxyphenyl group...
2019/0084989 MODULATION OF IRE1
Described herein, inter alia, are compositions and methods of using the same for modulating the activity of Ire1.
2019/0084988 WDR5 INHIBITORS AND MODULATORS
Described are N-(6-(6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl)-2,3-dihydro-1H-inden-1-- yl)benzamide and acetamide-containing compounds that inhibit WDR5 and ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.